Alyeska Investment Group Reports New 9.99% Stake in Kiora Pharmaceuticals via Warrants

On May 15, 2026, Alyeska Investment Group, L.P., along with Alyeska Fund GP, LLC and Anand Parekh, filed a Schedule 13G regarding their interest in Kiora Pharmaceuticals, Inc. (KPRX). As of the event date of March 31, 2026, the reporting persons reported beneficial ownership of 394,668 shares of common stock, representing 9.99% of the company. This position is entirely composed of shares issuable upon the exercise of warrants. Although the reporting persons hold warrants exercisable for a total of 596,854 shares, the warrants include a beneficial ownership limitation clause that prevents the holders from exercising them beyond a 9.99% threshold of the outstanding common stock. Alyeska Investment Group, L.P. serves as the investment manager for Alyeska Master Fund, L.P., which holds the underlying position. Anand Parekh, as CEO of the investment group, may be deemed to have shared voting and dispositive power over these shares. The filing indicates this is a new significant position for the group, as previous ownership was reported at 0%.